PUNE, India, June 22, 2016 /PRNewswire/ --
Atopic dermatitis (AD) is a chronic, inflammatory skin disease of unknown origin that usually starts in early infancy, but also affects a substantial number of adults. Atopic dermatitis is a long lasting skin disease that affects a large percentage of the world's population and is a special type of hypersensitivity that is associated with asthma, inhalant allergies (hay fever), and a chronic dermatitis. The symptoms of atopic dermatitis are itching, red to brownish grey patches and small raised bumps.
Complete report on atopic dermatitis market spread across 61 pages providing 4 company profiles and 2 tables and 53 charts is now available at http://www.marketreportsonline.com/482604.html.
The main cause of atopic dermatitis is unknown but it is assumed to be caused due to genetics, dry skin and environmental conditions. Multiple factors can trigger or worsen atopic dermatitis, including low humidity, seasonal allergies, exposure to harsh soaps and detergents, and cold weather. There has been no specified biologic till now for atopic dermatitis. But recent efforts by many companies have shown positive results and the first biologic may get launched in 2017. After that many other products are still in pipeline.
This report offers a comprehensive analysis of the atopic dermatitis market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global market is reined by few major players namely Sanofi, Glaxo Smithkline (GSK), AstraZeneca and Roche Holding. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
The key factors which are anticipated to drive atopic dermatitis market include increase in global population, improvement in the global health care expenditure, accelerated economic growth, pollution and climatic factors and role of triggers. Some of the significant developments of this industry include introduction of new biologics, biomarker in atopic dermatitis and opportunity for new entrants. However, the challenge to be faced ahead is time to be taken in drug adoption, high price and legal regulations.
Company Coverage of Atopic Dermatitis Market: Sanofi, GSK, AstraZeneca & Roche Holding. Purchase a copy of this Global Atopic Dermatitis Market research report at http://www.marketreportsonline.com/contacts/purchase.php?name=482604.
Major Points from Table of Contents Provided in Global Atopic Dermatitis Market 2016 Edition Report:
1. Atopic Dermatitis: An Introduction
2. Atopic Dermatitis - Global Market
3. Atopic Dermatitis - Regional Markets
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
List of Tables
List of Charts
Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.
MarketReportsOnline.com is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
SOURCE Market Reports Online